WILSON TROY EDWARD 4
4 · Kura Oncology, Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
WILSON TROY EDWARD
DirectorPresident and CEO
Transactions
- Award
Option to purchase common stock
2026-01-02+1,120,000→ 1,120,000 totalExercise: $10.34Exp: 2036-01-01→ Common Stock (1,120,000 underlying)
Footnotes (1)
- [F1]This option vests in 48 equal monthly installments commencing on the grant date.